200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 100-49-2

100-49-2

100-49-2 | Cyclohexanemethanol

CAS No: 100-49-2 Catalog No: AG000066 MDL No:MFCD00001510

Product Description

Catalog Number:
AG000066
Chemical Name:
Cyclohexanemethanol
CAS Number:
100-49-2
Molecular Formula:
C7H14O
Molecular Weight:
114.1855
MDL Number:
MFCD00001510
IUPAC Name:
cyclohexylmethanol
InChI:
InChI=1S/C7H14O/c8-6-7-4-2-1-3-5-7/h7-8H,1-6H2
InChI Key:
VSSAZBXXNIABDN-UHFFFAOYSA-N
SMILES:
OCC1CCCCC1
EC Number:
202-857-8
UNII:
4VDR6634UG
NSC Number:
5288

Properties

Complexity:
55.4  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
114.104g/mol
Formal Charge:
0
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
114.188g/mol
Monoisotopic Mass:
114.104g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
20.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.9  

Literature

Title Journal
Acceptorless photocatalytic dehydrogenation for alcohol decarbonylation and imine synthesis. Angewandte Chemie (International ed. in English) 20120820
Synthesis and structure of the β-carboline derivatives and their binding intensity with cyclin-dependent kinase 2. Chemical & pharmaceutical bulletin 20120101
Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors. Bioorganic & medicinal chemistry 20110101
Design and synthesis of novel hydroxyalkylaminomethylchromones for their IL-5 inhibitory activity. Bioorganic & medicinal chemistry 20100701
Synthesis and evaluation of novel chromone analogs for their inhibitory activity against interleukin-5. European journal of medicinal chemistry 20100601
The role of alkoxy group on the A ring of isoflavones in the inhibition of interleukin-5. Archives of pharmacal research 20070801
Highly beta-selective O-glucosidation due to the restricted twist-boat conformation. Organic letters 20070412
Structural requirement of chalcones for the inhibitory activity of interleukin-5. Bioorganic & medicinal chemistry 20070101
The role of the hydrophobic group on ring A of chalcones in the inhibition of interleukin-5. Archives of pharmacal research 20061101
Surface induced hydrogen-bonded macrocluster formation of methanol on silica surfaces. Langmuir : the ACS journal of surfaces and colloids 20051011
Turbidity determination of the critical exponent eta in the liquid-liquid mixture methanol and cyclohexane. The Journal of chemical physics 20040322
Glimepiride pharmacokinetics in obese versus non-obese diabetic patients. The Annals of pharmacotherapy 20040101
Characterization of polychlorinated aromatic hydrocarbons by reversed-phase liquid chromatography with ultraviolet absorbance and mass spectrometric detection. Journal of chromatography. A 20031017
What controls the thickness of wetting layers near bulk criticality? Physical review letters 20020826

© 2019 Angene International Limited. All rights Reserved.